||Recombinant Human FAM19A4 (Accession # NP_001005527) Ser35-Arg140 was produced in E. coli-derived.
|Predicted N Terminal:
||Lyophilized from a 0.2 µm filtered solution in PBS.
||Measured by its ability to enhance neurite outgrowth of E16-E18 rat embryonic cortical neurons.rhTAFA4, immobilized at 6 - 24 µg/mL on a 96-well plate, is able to significantly enhance neurite outgrowth.
||Recombinant Human FAM19A4 has a calculated MW of 11.7 kDa. In SDS-PAGE migrates as 11 kDa, reducing conditions.
||>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).